Gastroenteritis
Therapeutic area
Gastroenterology
Rare disease
No
- Definition
- An inflammatory disorder that affects the upper and lower gastrointestinal tract. Most commonly, this is attributed to viruses; however bacteria, parasites or adverse reactions can also be the culprit. Symptoms include acute diarrhea and vomiting.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Gastroenteritis
- Therapeutic area
- Gastroenterology
- gastroenteritis
- inflammation of intestine
- intestine inflammation
- infectious colitis, enteritis and gastroenteritis
- Disease mechanisms
- Inflammatory
- All therapeutic areas
- Gastroenterology
- Severity
- Mild
- MONDO ID
- MONDO:0002269
- Parent condition
- MONDO:0005020
Related records
Broader conditions (7)
- Digestive system disorder
- Disease
- Disease by body system or component
- Disease by developmental or physiological process
- Human disease
- Inflammatory disease
- Intestinal disorder
Narrower conditions (43)
- Amebic dysentery
- Appendicitis
- Campylobacter fetus infectious disease
- Campylobacteriosis
- Chemical colitis
- Cholera
- Clostridium difficile colitis
- Colitis
- Collagenous colitis
- Crohn ileitis
- Crohn jejunitis
- Crohn jejunoileitis
- Distal colitis
- Diversion colitis
- Duodenitis
- Dysentery
- Enteritis
- Eosinophilic colitis
- Eosinophilic gastritis
- Eosinophilic gastroenteritis
Trials (172)
- 24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE 3)
- A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
- A Multi-Site Clinical Evaluation of the ARIES Clostridium Difficile Assay in Symptomatic Patients
- A Retrospective, Blinded Validation of a Host-response Based Diagnostics
- A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
- A Study of E6011 in Participants With Active Crohn's Disease
- A Study on the Immune Response and Safety of Inactivated Poliovirus Vaccine (IPV) When Co-administered With Human Rotavirus (HRV) Porcine Circovirus (PCV)-Free Vaccine in Healthy Chinese Infants
- A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants.
- A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Japanese Participants With Eosinophilic Gastroenteritis
- A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis
- A Study to Evaluate the Safety and Efficacy of Domperidone in Pediatric Participants With Nausea and Vomiting Due to Acute Gastroenteritis
- A Study to Explore the Existence of Horizontal Transmission of the RIX4414 Vaccine Strain Between Twins Within a Family.
- A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in Germany
- A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
- A Trial Comparing the Effect of Oral Dimenhydrinate Versus Placebo in Children With Gastroenteritis
- A Two-Arm, Multi-Centre Clinical Evaluation of the xTAG Gastrointestinal Pathogen Panel
- Acute Gastroenteritis: Development of PCR Analysis and Algorithm for Fast Clarification of Isolation Indication
- Admission Pattern Among Children With Gastro-intestinal Infections Before and During the Covid-19 Pandemic
- An Alternate Dosing Schedule for Pentavalent Rotavirus Vaccine (RotaTeq)
- Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine at Different Viral Concentrations in Healthy Infants
Drugs in development (14)
- Ciprofloxacin Phase 1
- Dipyrone Phase 3
- Domperidone Phase 3
- Inulin Phase 1
- Metoclopramide Phase 3
- Microcrystalline cellulose Phase 2
- Nitazoxanide Phase 2
- Omalizumab Phase 2
- Ondansetron Phase 3
- Papaverine Phase 3
- Poliovirus vaccine inactivated Phase 3
- Prulifloxacin Phase 3
- Sodium chloride Phase 1
- Tannic acid Phase 3